A study of adverse drug reactions in pediatric patients

Journal of Pharmacology and Pharmacotherapeutics

Volumn 2, Issue 4, 2011, Pages 277-280

  Priyadharsini, R ^a   Surendiran, A ^a   Adithan, C ^a   Sreenivasan, S ^a   Sahoo, Firoj Kumar ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Adverse drug reaction; causality; pediatric; pharmacovigilance

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFIXIME; CIPROFLOXACIN; CLOXACILLIN; DIGOXIN; DOMPERIDONE; FAMOTIDINE; FUROSEMIDE; MEROPENEM; OMEPRAZOLE; PHENYTOIN; THIOPENTAL; VANCOMYCIN;

ADVERSE DRUG REACTION; ADVERSE OUTCOME; ANAPHYLACTIC SHOCK; APHTHOUS ULCER; ARTICLE; BRADYCARDIA; BURNING SENSATION; CHILD; CHILL; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; DRUG TREATMENT FAILURE; DYSTONIA; FEMALE; HUMAN; INCIDENCE; INFANT; MALE; MONOTHERAPY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PEDIATRICS; PRESCHOOL CHILD; RATING SCALE; RIGOR; SCORING SYSTEM; SEIZURE; URTICARIA; VOMITING;

EID: 84865474632     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.85957     Document Type: Article

References (25)

1. Chien J Y, Ho RJ. Drug delivery trends in clinical trials and translational medicine: Evaluation of pharmacokinetic properties in special populations. J Pharm Sci 2011;100:53-8.
2. Aagaard L, Hansen EH. Adverse drug reactions reported for systemic antibacterials in Danish children over a decade. Br J Clin Pharmacol 2010;70:765-8.
3. Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics 2006;118:555-62.
4. Bavdekar SB, Karande S. National pharmacovigilance program. Indian Pediatr 2006;43:27-32.
5. Clavenna A, Bonati M. Adverse drug reactions in childhood: A review of prospective studies and safety alerts. Arch Dis Child 2009;94:724-8.
6. Johann-Liang R, Wyeth J, Chen M, Cope JU. Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: An overview of reports, 2003-2007. Pharmacoepidemiol Drug Saf 2009;18:24-7.
7. Drop box. Uppsala Reports. Available from: http://www.who-umc.org/ graphics/9628.pdf. [last cited on 2010 Dec 24].
8. ADR form. Available from http://www.cdsco.nic.in/pharmacovigilance.htm [last cited on 2011 May 8].
9. Skrbo A, Zulic I, Hadzic S, Gaon ID. (Anatomic-therapeutic-chemical classification of drugs). Med Arh 1999;53:57-60.
10. Skrbo A, Begovic B, Skrbo S. [Classification of drugs using the ATC system (Anatomic, Therapeutic, Chemical Classification) and the latest changes]. Med Arh 2004;58:138-41.
11. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
12. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49:2229-32.
13. Schumock GT, Seeger JD, Kong SX. Control charts to monitor rates of adverse drug reactions. Hosp Pharm 1995;30:1088, 1091-2, 1095-6.
14. Schumock GT, Thornton J P. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992;27:538.
15. Brunlof G, Tukukino C, Wallerstedt SM. Individual case safety reports in children in commonly used drug groups - signal detection. BMC Clin Pharmacol 2008;8:1.
16. Berry MA, Shah PS, Brouillette RT, Hellmann J. Predictors of mortality and length of stay for neonates admitted to children's hospital neonatal intensive care units. J Perinatol 2008;28:297-302.
17. Neubert A, Dormann H, Weiss J, Egger T, Criegee-Rieck M, Rascher W, et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 2004;27:1059-67.
18. Moore TJ, Weiss SR, Kaplan S, Blaisdell CJ. Reported adverse drug events in infants and children under 2 years of age. Pediatrics 2002;110:e53.
19. Segal AR, Doherty KM, Leggott J, Zlotoff B. Cutaneous reactions to drugs in children. Pediatrics 2007;120:e1082-96.
20. Titchen T, Cranswick N, Beggs S. Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospital. Br J Clin Pharmacol 2005;59:718-23.
21. McMahon AW, Iskander J, Haber P, Chang S, Woo EJ, Braun MM, et al. Adverse events after inactivated influenza vaccination among children less than 2 years of age: Analysis of reports from the vaccine adverse event reporting system, 1990-2003. Pediatrics 2005;115:453-60.
22. Buajordet I, Wesenberg F, Brors O, Langslet A. Adverse drug events in children during hospitalization and after discharge in a Norwegian university hospital. Acta Paediatr 2002;91:88-94.
23. dos Santos DB, Coelho HL. Adverse drug reactions in hospitalized children in Fortaleza, Brazil. Pharmacoepidemiol Drug Saf 2006;15:635-40.
24. Oshikoya KA, Senbanjo IO, Njokanma O F. Parental reporting of suspected adverse drug reactions in children in Lagos, Nigeria. Arch Dis Child 2009;94:469-73.
25. Dharnidharka VR, Kandoth PN, Anand RK. Adverse drug reactions in pediatrics with a study of in-hospital intensive surveillance. Indian Pediatr 1993;30:745-51.